Earnings Call · Q3 FY2021·2021-10-27

Q3 21EPS -7.81%·Rev n/aQ2 21EPS -6.35%·Rev n/aQ1 21EPS +3.28%·Rev n/aQ4 20EPS +7.94%·Rev n/a⚠ consensus missing

TEVA PHARMACEUTICAL INDUSTRIES LTD TEVJF

Kevin Mannix — Investor Relations or Communications Officer

Kare Schultz — Chief Executive Officer

Eli Kalif — Chief Financial Officer

0.0%1d on move date+0.4% vs SPY3d0.0%5d+3.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TEVJF calls or request research access.

More TEVJF calls Browse calls Request research access